Literature DB >> 8605733

Predominance of the metastatic phenotype in hybrids formed by fusion of mouse and human melanoma clones.

K L van Golen1, S Risin, A Staroselsky, D Berger, M A Tainsky, S Pathak, J E Price.   

Abstract

The fusion of mouse and human melanoma cells that were tumorigenic but had different metastatic capabilities resulted in hybrids that were metastatic when injected intravenously or subcutaneously into nude mice, regardless of whether it was the mouse or the human melanoma clone that was metastatic. The H7 hybrid line, formed by fusing murine nonmetastatic K1735 C19 cells with human metastatic A375 C15 cells retained high metastatic potential over more than 50 sub-culture passages, suggesting that the dominant metastatic phenotype in these hybrid cells was stable. Using fluorescent in situ hybridization (FISH), human chromosome 17 was consistently identified as the predominant human chromosome in the majority of H7 cells tested between passages 20 and 60. Western blot analysis showed that the hybrid cells expressed human nm23 protein, indicating that at least one gene on the human chromosome 17 was functional. Immunocytochemistry and immunoprecipitation showed that the metastatic A375 C15 and H7 cells expressed p53 protein, but that the nonmetastatic K1735 C19 melanoma cells did not. Sequencing the human p53 gene in A375 C15N and H7 showed mutations in exon 7. Using a bioassay technique, we showed that K1735 C19 cells can spread from subcutaneous tumors to the lungs of nude mice yet fail to form metastases. With the addition of human chromosome 17 from A375 C15 cells, which carries a mutant p53 gene, the cells readily formed lung metastases. In this melanoma hybrid, a mutant p53 gene appears to confer a survival advantage on cells arrested in the lungs of nude mice and thus contributes to the growth of metastatic cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8605733     DOI: 10.1007/bf00121206

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  64 in total

1.  Expression of p53 protein in cutaneous melanoma.

Authors:  L A Akslen; O Mørkve
Journal:  Int J Cancer       Date:  1992-08-19       Impact factor: 7.396

Review 2.  Growth dominance of the metastatic cancer cell: cellular and molecular aspects.

Authors:  R S Kerbel
Journal:  Adv Cancer Res       Date:  1990       Impact factor: 6.242

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  The pathogenesis of cancer metastasis.

Authors:  G Poste; I J Fidler
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

5.  High frequency of p53 mutations in ultraviolet radiation-induced murine skin tumors: evidence for strand bias and tumor heterogeneity.

Authors:  S Kanjilal; W E Pierceall; K K Cummings; M L Kripke; H N Ananthaswamy
Journal:  Cancer Res       Date:  1993-07-01       Impact factor: 12.701

6.  Expression level of the nm23 gene in clonal populations of metastatic murine and human neoplasms.

Authors:  R Radinsky; H Z Weisberg; A N Staroselsky; I J Fidler
Journal:  Cancer Res       Date:  1992-10-15       Impact factor: 12.701

7.  Alteration of the tumorigenic and metastatic properties of neoplastic cells is associated with the process of calcium phosphate-mediated DNA transfection.

Authors:  R S Kerbel; C Waghorne; M S Man; B Elliott; M L Breitman
Journal:  Proc Natl Acad Sci U S A       Date:  1987-03       Impact factor: 11.205

8.  Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms.

Authors:  M A Cifone; I J Fidler
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

9.  Differential suppression of mammary and prostate cancer metastasis by human chromosomes 17 and 11.

Authors:  C W Rinker-Schaeffer; A L Hawkins; N Ru; J Dong; G Stoica; C A Griffin; T Ichikawa; J C Barrett; J T Isaacs
Journal:  Cancer Res       Date:  1994-12-01       Impact factor: 12.701

10.  Predominance of the metastatic phenotype in somatic cell hybrids of the K-1735 murine melanoma.

Authors:  A H Staroselsky; S Pathak; Y Chernajovsky; S L Tucker; I J Fidler
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

View more
  13 in total

1.  Epstein-Barr virus protein can upregulate cyclo-oxygenase-2 expression through association with the suppressor of metastasis Nm23-H1.

Authors:  Rajeev Kaul; Subhash C Verma; Masanao Murakami; Ke Lan; Tathagata Choudhuri; Erle S Robertson
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

2.  Suppression of human melanoma metastasis following introduction of chromosome 6 is independent of NME1 (Nm23).

Authors:  M E Miele; A De La Rosa; J H Lee; D J Hicks; J U Dennis; P S Steeg; D R Welch
Journal:  Clin Exp Metastasis       Date:  1997-05       Impact factor: 5.150

3.  Epstein-Barr virus nuclear antigen 1 interacts with Nm23-H1 in lymphoblastoid cell lines and inhibits its ability to suppress cell migration.

Authors:  Masanao Murakami; Ke Lan; Chitra Subramanian; Erle S Robertson
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

4.  Expression patterns of ER, HER2, and NM23-H1 in breast cancer patients with different menopausal status: correlations with metastasis.

Authors:  Su-Wei Dong; Lin Wang; Jun Sui; Xi-Yun Deng; Xiao-Dan Chen; Zhi-Wei Zhang; Xu Liu; Zhi-Min Liu; Jian-Hua Zhang; Qi-Sheng Yang; Yong-Feng Jia; Xin Song
Journal:  Mol Diagn Ther       Date:  2011-08-01       Impact factor: 4.074

Review 5.  Functional modulation of the metastatic suppressor Nm23-H1 by oncogenic viruses.

Authors:  Abhik Saha; Erle S Robertson
Journal:  FEBS Lett       Date:  2011-08-11       Impact factor: 4.124

6.  Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer.

Authors:  Kenneth L van Golen; Li Wei Bao; Quintin Pan; Fred R Miller; Zhi Fen Wu; Sofia D Merajver
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

7.  Enhancement of migration and invasion of hepatoma cells via a Rho GTPase signaling pathway.

Authors:  De-Sheng Wang; Ke-Feng Dou; Kai-Zong Li; Zhen-Shun Song
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

8.  EBNA3C can modulate the activities of the transcription factor Necdin in association with metastasis suppressor protein Nm23-H1.

Authors:  Rajeev Kaul; Masanao Murakami; Ke Lan; Tathagata Choudhuri; Erle S Robertson
Journal:  J Virol       Date:  2008-12-30       Impact factor: 5.103

9.  Epstein-Barr virus latent nuclear antigens can induce metastasis in a nude mouse model.

Authors:  Rajeev Kaul; Masanao Murakami; Tathagata Choudhuri; Erle S Robertson
Journal:  J Virol       Date:  2007-07-18       Impact factor: 5.103

10.  Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma.

Authors:  Kenneth L van Golen; LiWei Bao; George J Brewer; Kenneth J Pienta; Jeffrey M Kamradt; Donna L Livant; Sofia D Merajver
Journal:  Neoplasia       Date:  2002 Sep-Oct       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.